| Thypoid |
160 |
0 |
12 |
64 |
49 |
35 |
160 |
7.52 |
2017 |
| GEA / Diare |
220 |
12 |
35 |
95 |
62 |
26 |
220 |
1,034 |
2017 |
| Gastritis |
36 |
0 |
0 |
5 |
21 |
10 |
36 |
1.69 |
2017 |
| KLL |
20 |
0 |
1 |
2 |
15 |
2 |
20 |
0.94 |
2017 |
| Pharingitis |
23 |
1 |
5 |
14 |
3 |
0 |
23 |
1.08 |
2017 |
| T B Paru |
22 |
0 |
1 |
4 |
9 |
8 |
22 |
1.03 |
2017 |
| Hypertensi |
59 |
0 |
0 |
0 |
21 |
38 |
59 |
2.77 |
2017 |
| Bronchitis |
74 |
0 |
2 |
25 |
27 |
20 |
74 |
3.48 |
2017 |
| Tonsilitis |
68 |
6 |
24 |
28 |
10 |
0 |
68 |
3.2 |
2017 |
| Hepatitis |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2017 |
| Lain-lain |
1,446 |
190 |
214 |
322 |
196 |
524 |
1,446 |
67.95 |
2017 |
| Thypoid |
227 |
0 |
0 |
1 |
26 |
148 |
52 |
10 |
2018 |
| GEA / Diare |
267 |
0 |
2 |
5 |
74 |
87 |
99 |
12 |
2018 |
| Gastritis |
48 |
0 |
1 |
2 |
5 |
21 |
19 |
2 |
2018 |
| KLL |
20 |
0 |
0 |
0 |
12 |
5 |
3 |
1 |
2018 |
| Pharingitis |
47 |
0 |
0 |
3 |
21 |
14 |
9 |
2 |
2018 |
| T B Paru |
8 |
0 |
0 |
0 |
1 |
2 |
5 |
0 |
2018 |
| Hypertensi |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2018 |
| Bronchitis |
36 |
0 |
1 |
7 |
11 |
9 |
8 |
2 |
2018 |
| Tonsilitis |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2018 |
| Hepatitis |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2018 |
| Lain-lain |
1,521 |
0 |
21 |
241 |
541 |
355 |
363 |
70 |
2018 |
| Thypoid |
383 |
0 |
0 |
4 |
45 |
182 |
152 |
14.24% |
2019 |
| GEA / Diare |
181 |
0 |
12 |
65 |
54 |
31 |
19 |
6.73% |
2019 |
| Gastritis |
19 |
0 |
0 |
0 |
3 |
12 |
4 |
0.71% |
2019 |
| KLL |
27 |
0 |
0 |
0 |
15 |
7 |
5 |
1.00% |
2019 |
| Pharingitis |
19 |
0 |
1 |
10 |
5 |
2 |
1 |
0.71% |
2019 |
| T B Paru |
18 |
0 |
0 |
0 |
0 |
6 |
12 |
0.67% |
2019 |
| Hypertensi |
12 |
0 |
0 |
0 |
0 |
4 |
8 |
0.45% |
2019 |
| Bronchitis |
60 |
0 |
0 |
5 |
11 |
25 |
19 |
2.23% |
2019 |
| Tonsilitis |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.00% |
2019 |
| Hepatitis |
3 |
0 |
0 |
0 |
0 |
2 |
1 |
0.11% |
2019 |
| Lain-lain |
2 |
0 |
241 |
112 |
574 |
456 |
585 |
73.16% |
2019 |
| Thypoid |
266 |
0 |
15 |
23 |
87 |
76 |
114 |
0 |
2020 |
| GEA / Diare |
527 |
0 |
18 |
82 |
110 |
125 |
60 |
0 |
2020 |
| Gastritis |
198 |
0 |
0 |
21 |
11 |
82 |
2 |
0 |
2020 |
| KLL |
24 |
0 |
0 |
2 |
6 |
9 |
1 |
0 |
2020 |
| Pharingitis |
1,215 |
0 |
124 |
241 |
321 |
251 |
0 |
0 |
2020 |
| T B Paru |
17 |
0 |
0 |
1 |
4 |
5 |
14 |
0 |
2020 |
| Hypertensi |
16 |
0 |
0 |
0 |
0 |
13 |
30 |
0 |
2020 |
| Bronchitis |
393 |
0 |
12 |
65 |
85 |
153 |
78 |
0 |
2020 |
| Tonsilitis |
461 |
0 |
0 |
0 |
0 |
142 |
319 |
0 |
2020 |
| Hepatitis |
16 |
0 |
0 |
0 |
0 |
2 |
14 |
0 |
2020 |
| Lain-lain |
13,922 |
0 |
425 |
852 |
712 |
921 |
921 |
0 |
2020 |
| Thypoid |
338 |
0 |
0 |
74 |
85 |
131 |
48 |
18.29% |
2021 |
| GEA / Diare |
164 |
0 |
11 |
18 |
52 |
17 |
66 |
8.87% |
2021 |
| Gastritis |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0.05% |
2021 |
| KLL |
12 |
0 |
0 |
0 |
4 |
8 |
0 |
0.65% |
2021 |
| Pharingitis |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.00% |
2021 |
| T B Paru |
21 |
0 |
0 |
0 |
4 |
7 |
10 |
1.14% |
2021 |
| Hypertensi |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.00% |
2021 |
| Bronchitis |
52 |
0 |
0 |
11 |
14 |
21 |
6 |
2.81% |
2021 |
| Tonsilitis |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.00% |
2021 |
| Hepatitis |
2 |
0 |
0 |
0 |
0 |
1 |
1 |
0.11% |
2021 |
| Lain-lain |
1,258 |
0 |
88 |
412 |
214 |
251 |
293 |
68.07% |
2021 |
| Thypoid |
450 |
0 |
0 |
0 |
0 |
0 |
0 |
20.62% |
2022 |
| Gea/ Diare |
273 |
0 |
44 |
76 |
38 |
23 |
99 |
12.51% |
2022 |
| Gastritis |
234 |
0 |
0 |
0 |
0 |
123 |
217 |
10.72% |
2022 |
| KLL |
236 |
0 |
0 |
31 |
40 |
108 |
58 |
10.82% |
2022 |
| Pharingitis |
216 |
0 |
0 |
0 |
1 |
0 |
215 |
9.90% |
2022 |
| TB Paru |
186 |
0 |
0 |
6 |
34 |
102 |
48 |
8.52% |
2022 |
| Hypertensi |
185 |
0 |
184 |
0 |
0 |
0 |
0 |
8.48% |
2022 |
| Bronchitis |
152 |
0 |
156 |
0 |
0 |
0 |
0 |
6.97% |
2022 |
| Tonsilitis |
152 |
0 |
0 |
0 |
40 |
110 |
2 |
6.97% |
2022 |
| Hepatitis |
98 |
0 |
9 |
1 |
9 |
39 |
31 |
4.49% |
2022 |
| Lain-lain |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.00% |
2022 |
| Thypoid |
425 |
0 |
2 |
75 |
81 |
147 |
155 |
27.94% |
2023 |
| Gea/ Diare |
55 |
0 |
12 |
15 |
9 |
8 |
12 |
3.62% |
2023 |
| Gastritis |
13 |
0 |
0 |
0 |
1 |
9 |
3 |
0.85% |
2023 |
| KLL |
240 |
0 |
0 |
30 |
41 |
100 |
63 |
15.78% |
2023 |
| Pharingitis |
216 |
0 |
0 |
0 |
1 |
0 |
215 |
14.20% |
2023 |
| TB Paru |
35 |
0 |
0 |
0 |
0 |
6 |
25 |
2.30% |
2023 |
| Hypertensi |
9 |
0 |
0 |
0 |
0 |
4 |
5 |
0.59% |
2023 |
| Bronchitis |
22 |
0 |
2 |
8 |
8 |
3 |
1 |
1.45% |
2023 |
| Tonsilitis |
152 |
0 |
0 |
0 |
40 |
110 |
2 |
9.99% |
2023 |
| Hepatitis |
98 |
0 |
9 |
1 |
9 |
39 |
31 |
6.44% |
2023 |
| Lain-lain |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.00% |
2023 |
| Kolera |
40 |
0 |
10 |
5 |
6 |
13 |
16 |
5.06% |
2024 |
| Demam tifoid dan paratifoid |
608 |
0 |
8 |
80 |
114 |
251 |
155 |
76.96% |
2024 |
| Sigelosis |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.00% |
2024 |
| Abses hati amuba |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.00% |
2024 |
| Amebiasis lainnya |
5 |
0 |
0 |
0 |
0 |
2 |
3 |
0.63% |
2024 |
| Diare & gastroenteritis oleh penyebab Infeksi tertentu (kolitis infeksi) |
96 |
0 |
12 |
42 |
16 |
14 |
12 |
12.15% |
2024 |
| Penyakit infeksi usus lainnya |
5 |
0 |
0 |
0 |
0 |
4 |
1 |
0.63% |
2024 |
| Tuberkulosis (TB) paru BTA (+) dengan/tanpa tindakan kuman TB |
24 |
0 |
0 |
0 |
2 |
4 |
18 |
3.04% |
2024 |
| Tuberkulosis paru lainnya |
11 |
0 |
0 |
0 |
0 |
2 |
9 |
1.39% |
2024 |
| Tuberkulosis alat napas lainnya |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0.13% |
2024 |
| Lain-lain |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.00% |
2024 |